Form 4: Reprogrammed Interchange LLC and Reid Hoffman Acquire Significant Stake in Vor Biopharma Inc.

Reprogrammed Interchange LLC and Reid Hoffman have acquired a substantial amount of Vor Biopharma Inc. common stock and warrants, increasing their beneficial ownership.

Summary

• Reprogrammed Interchange LLC purchased 38,974,101 shares of Vor Biopharma Inc. common stock on December 30, 2024.
• Each share was purchased along with a warrant to buy 1.25 additional shares.
• The purchase price was $0.99425 per share and accompanying warrant.
• Reprogrammed also acquired 48,717,626 warrants with an exercise price of $0.838 per share, exercisable immediately but with a 9.99% ownership cap.
• Reid Hoffman may be deemed a beneficial owner of the securities held by Reprogrammed due to his shared control and indirect pecuniary interest.
• Mr. Hoffman disclaims beneficial ownership except to the extent of his pecuniary interest.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive due to the significant investment by Reprogrammed and Reid Hoffman, indicating confidence in the company. However, the 9.99% ownership cap and disclaimer of beneficial ownership by Reid Hoffman temper the overall positive sentiment.

Positives

• The acquisition represents a significant investment in Vor Biopharma Inc.
• The purchase of warrants indicates a potential for further investment and increased ownership in the future.
• The immediate exercisability of the warrants provides flexibility for the investors.

Negatives

• The 9.99% ownership cap on warrant exercises could limit the potential for further ownership increases.

Risks

• The 9.99% ownership cap on warrant exercises could limit the potential for further ownership increases.
• The disclaimer of beneficial ownership by Reid Hoffman, except for his pecuniary interest, could create uncertainty about his level of control.

Future Outlook

The document does not contain any specific forward-looking statements or guidance.

Management Comments

• Reid Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest.

Industry Context

This filing indicates a significant investment in a biotechnology company, which is a common occurrence in the life sciences sector. Such investments can signal confidence in the company's prospects and technology.

Comparison to Industry Standards

• Acquisitions of this size are not uncommon in the biotech industry, where large investments are often made in companies with promising technologies.
• The structure of the deal, including the purchase of both common stock and warrants, is a typical method for investors to gain exposure to potential upside while managing risk.
• Similar transactions can be seen with other biotech companies such as Xencor and Arcus Biosciences, where large investors take significant positions through a combination of stock and warrants.

Stakeholder Impact

• The acquisition could positively impact shareholders by increasing confidence in the company.
• The investment may lead to further growth and development for the company, potentially benefiting employees and other stakeholders.

Key Dates

Keywords

Vor Biopharma Inc., Reprogrammed Interchange LLC, Reid Hoffman, common stock, warrants, beneficial ownership, investment, SEC Form 4